{
  "trial_id": "NCT02088866",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "informed consent process",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "full history and physical exam",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "an audiogram performed as standard of care for evaluation and management of chronic tinnitus",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "transdermal lidocaine patches will be administered to the participant's torso, either the upper back or chest, at his or her preference",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "patches will be applied first thing in the morning to these areas daily, and kept on for twelve hours",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "all relevant patient information including symptoms checklists, results of TFI, and other important patient care information will be recorded in the UC Davis Electronic Medical Record (EMR) for each encounter under the appropriate encounter subheading",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "the patient data will also be transposed into a REDCap database for patient tracking, evaluation, and analysis",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "each participant will continue with either the baseline dosage or an increased dosage based upon his or her response and tolerance to the drug",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "the participant will be asked to follow-up in 4 weeks by phone",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "each participant will be prescribed thirty transdermal lidocaine patches, so that one patch can be applied daily for 12 hours, as indicated by the manufacturer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "the participant will undergo a twelve hour drug recess off of the transdermal lidocaine following patch removal at night",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "all subjects will be enrolled sequentially and assigned a schedule that works best with his or her ability to follow-up",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of heart disease",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "History of irregular heartbeat",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Prior MI",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Previous exposure to lidocaine as a treatment for tinnitus",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "An allergy to adhesives",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Allergy to lidocaine.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Taking medications, herbal remedies and supplements that may interact with lidocaine, including but not limited to antivirals, benzodiazepines, and St. John's Wart",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Known liver disease",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He has hypertension and hypercholesterolemia in his past medical history.",
  "_meta": {
    "topic_id": "75",
    "trial_id": "NCT02088866",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}